January 27, 2024

Neurokappa Therapeutics LLC works with Penn Wharton Venture Acceleration Lab for drug development in the Spring of 2024

December 15, 2023

Neurokappa Therapeutics LLC forms partnership for Quotient Science for business development.

December 2, 2023

Congratulations to Neurokappa Therapeutics for the Third Place for the pitch contest for the technology of dezocine for addiction therapy

at 2023 Wharton Innovation Summit!

Click to view the large image

October 30, 2023

Congratulations to Professor Gordon Barr (PhD) finished his L-PRINT entrepreneurship program sponsored by NIDA!

Here is his pitch presentation at the conclusion of the program:

September 1, 2023

Dr. Renyu Liu, the founder of Neurokappa Therapeutics, is appointed as a Co-Director at the Penn Psychedelics Collaborative

July 7, 2023

Professor Gordon Barr (PhD) and his proposal to use dezocine to manage opioid crisis are accepted to the L-PRINT entrepreneurship program sponsored by NIDA to be held in Boston in Oct, 2023



Neurokappa Therapeutics is now a member of PA Life Science!

The team attended and presented in PA life science event

Date: 10/7/2022!

Event Name:  Life Sciences Future – BioPharm

Location: Hilton City Ave, Piladelphia, PA

Scroll to top